Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Viking Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Mar 31, 2025 | Viking Therapeutics Inc. | Open-market purchase | +1,240 | $24.15 | $29,946 |
| Oct 25, 2024 | Viking Therapeutics Inc. | Option exercise | +11,000 | $4.88 | $53,680 |
| Oct 25, 2024 | Viking Therapeutics Inc. | Open-market sale | −11,000 | $80.89 | $889,790 |
| Feb 8, 2024 | Viking Therapeutics Inc. | Option exercise | +25,000 | $8.32 | $208,000 |
| Feb 8, 2024 | Viking Therapeutics Inc. | Open-market sale | −25,000 | $28.05 | $701,250 |
| Jan 19, 2024 | Viking Therapeutics Inc. | Option exercise | +30,000 | $8.32 | $249,600 |
| Jan 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −30,000 | $23.05 | $691,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.